HUD OIG is one of 10 OIGs participating in this PRAC-led COVID 19 Pandemic Impact Project. The OIGs will conduct the review and provide the results to the PRAC for the final consolidated work products.
Search
Lessons Learned and Key Considerations From Prior Audits and Evaluations of the CDBG Disaster Recovery Program
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act made available $5 billion in supplemental CDBG funding for grants to prevent, prepare for, and respond to the coronavirus pandemic (CDBG-CV grants). Because of similarities, we reviewed 132 CDBG-DR program audits and evaluations issued from May 2002 to March 2020 to summarize the common CDBG-DR program weaknesses and risks
HUD's Processes for Addressing Cases of Children Residing in Public Housing with Elevated Blood Lead Levels
The Office of Evaluation is initiating an evaluation of HUD’s processes for addressing cases of children residing in public housing with elevated blood lead levels (EBLL). The objectives are to: 1. Use available information to identify HUD-assisted properties owned and managed by public housing agencies at risk of having lead-based paint hazards. 2.
Impact of COVID-19 on Nursing Homes
HUD OIG is conducting a review of HUD's Office of Residential Care Facilities. Media reports have shown that the COVID-19 virus impacted nursing homes nationwide. Our audit objective is to determine the biggest challenges that nursing home owners face related to COVID-19 and whether they are prepared to meet their future financial obligations.
HUD's Reopening of Offices to Employees During COVID-19
HUD OIG is reviewing HUD's plans to reopen its offices to its employees. This work is in response to a Congressional request. The review objective is to determine whether HUD is following (1) its Resuming Normal Operations Guide, COVID-19 Response, Headquarters and Field Offices; (2) Federal, State, and local government and appropriate non-governmental guidance; and (3) best practices in reopening its offices to employees.